ZA200807614B - Buprenorphine derivatives and uses thereof - Google Patents
Buprenorphine derivatives and uses thereofInfo
- Publication number
- ZA200807614B ZA200807614B ZA200807614A ZA200807614A ZA200807614B ZA 200807614 B ZA200807614 B ZA 200807614B ZA 200807614 A ZA200807614 A ZA 200807614A ZA 200807614 A ZA200807614 A ZA 200807614A ZA 200807614 B ZA200807614 B ZA 200807614B
- Authority
- ZA
- South Africa
- Prior art keywords
- buprenorphine derivatives
- buprenorphine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0606124.6A GB0606124D0 (en) | 2006-03-28 | 2006-03-28 | Buprenorphine derivatives and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200807614B true ZA200807614B (en) | 2009-10-28 |
Family
ID=36384277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200807614A ZA200807614B (en) | 2006-03-28 | 2008-09-04 | Buprenorphine derivatives and uses thereof |
Country Status (21)
Country | Link |
---|---|
US (1) | US7964610B2 (xx) |
EP (1) | EP2001891B1 (xx) |
JP (1) | JP5167446B2 (xx) |
KR (1) | KR101430626B1 (xx) |
CN (2) | CN101410402A (xx) |
AU (1) | AU2007231133B2 (xx) |
BR (1) | BRPI0709157A8 (xx) |
CA (1) | CA2647417C (xx) |
DK (1) | DK2001891T3 (xx) |
ES (1) | ES2432169T3 (xx) |
GB (1) | GB0606124D0 (xx) |
IL (1) | IL193917A (xx) |
MX (1) | MX2008011984A (xx) |
MY (1) | MY151025A (xx) |
NZ (1) | NZ570997A (xx) |
PL (1) | PL2001891T3 (xx) |
PT (1) | PT2001891E (xx) |
RU (1) | RU2435773C2 (xx) |
TW (1) | TWI501969B (xx) |
WO (1) | WO2007110636A1 (xx) |
ZA (1) | ZA200807614B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2549115T3 (es) | 2006-09-22 | 2015-10-23 | Zynerba Pharmaceuticals, Inc. | Profármacos de buprenorfina administrables por vía transdérmica y composiciones resistentes al consumo excesivo de los mismos |
SI2307420T1 (sl) * | 2008-04-24 | 2012-05-31 | Janssen Pharmaceutica Nv | Predzdravila nalmefen di estra |
FR2975912B1 (fr) | 2011-05-30 | 2013-06-14 | Flamel Tech Sa | Composition a liberation controlee de buprenorphine |
JP2018531955A (ja) * | 2015-10-26 | 2018-11-01 | オーフォームド,インコーポレイティド | ブプレノルフィンのエチレングリコールエーテル |
EP3426234A1 (en) | 2016-03-09 | 2019-01-16 | Indivior UK Limited | Abuse-resistant pharmaceutical formulations |
AU2017325910B2 (en) * | 2016-09-13 | 2020-08-27 | Alar Pharmaceuticals Inc. | Sustained-release buprenorphine formulations |
WO2019064026A1 (en) | 2017-09-29 | 2019-04-04 | Orexo Ab | NEW PHARMACEUTICAL COMPOSITIONS |
GB201904767D0 (en) | 2019-04-04 | 2019-05-22 | Orexo Ab | New pharmaceutical compositions |
WO2023102489A1 (en) * | 2021-12-03 | 2023-06-08 | Board Of Regents Of The University Of Nebraska | Compounds, nanoparticles, and pharmaceutical compositions for the treatment of drug addiction |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4668685A (en) * | 1984-07-05 | 1987-05-26 | E.I. Du Pont De Nemours And Company | Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists |
GB8728294D0 (en) * | 1987-12-03 | 1988-01-06 | Reckitt & Colmann Prod Ltd | Treatment compositions |
US5985880A (en) * | 1996-06-05 | 1999-11-16 | Delta Pharmaceuticals | Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
US5512593A (en) * | 1993-03-02 | 1996-04-30 | John S. Nagle | Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor |
US5750534A (en) * | 1994-03-16 | 1998-05-12 | National Science Council | Nalbuphine esters having long acting analgesic action and method of use |
US6004969A (en) * | 1996-04-15 | 1999-12-21 | National Science Council | Transdermal delivery of buprenorphine preparations |
KR100204659B1 (ko) * | 1996-05-28 | 1999-06-15 | 강재헌 | 신규한 부프레노핀계 진통제용 화합물 |
US6225321B1 (en) * | 1997-06-05 | 2001-05-01 | Oliver Yoa-Pu Hu | Long analgesic acting nalbuphine polyester derivative and method of use |
EP2266548B1 (de) | 1998-11-13 | 2020-05-20 | Jagotec AG | Trockenpulver zur inhalation |
AP1665A (en) * | 2000-02-08 | 2006-09-22 | Euro Celtique Sa | Tamper-resistant oral opioid agonist formulations. |
US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
WO2003026743A2 (en) * | 2001-09-26 | 2003-04-03 | Penwest Pharmaceuticals Company | Opioid formulations having reduced potential for abuse |
US20040033253A1 (en) * | 2002-02-19 | 2004-02-19 | Ihor Shevchuk | Acyl opioid antagonists |
US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
US7776314B2 (en) * | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
US20050186139A1 (en) * | 2002-10-25 | 2005-08-25 | Gruenenthal Gmbh | Abuse-proofed dosage form |
US20050191244A1 (en) * | 2002-10-25 | 2005-09-01 | Gruenenthal Gmbh | Abuse-resistant pharmaceutical dosage form |
DE10250084A1 (de) * | 2002-10-25 | 2004-05-06 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE10250087A1 (de) | 2002-10-25 | 2004-05-06 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
ATE444296T1 (de) * | 2002-10-25 | 2009-10-15 | Euro Celtique Sa | Analoga und prodrugs von buprenorphin |
CN1263760C (zh) | 2002-11-12 | 2006-07-12 | 财团法人奇美医院 | 新颖的丁丙诺啡酯衍生物及其制备方法,以及长效作用镇痛药学组合物 |
ATE382050T1 (de) * | 2002-11-25 | 2008-01-15 | Chi Mei Foundation Medical Ct | Buprenorphinesterderivate, verfahren zu ihrer herstellung, und langwirksame analgetische arzneimittel |
JP2004175706A (ja) * | 2002-11-26 | 2004-06-24 | Chi Mei Foundation Medical Center | 新規なブプレノルフィンのエステル誘導体及びそれらの調製方法、及び長時間効力持続性鎮痛薬剤組成物 |
TW200500067A (en) * | 2003-01-21 | 2005-01-01 | Control Delivery Sys Inc | Salts of codrugs and uses related thereto |
JP2006516963A (ja) * | 2003-02-04 | 2006-07-13 | クリサリス テクノロジーズ インコーポレイテッド | エアロゾル製剤及びブスピロン、ブプレノルフィン、トリアゾラム、シクロベンザプリン及びゾルピデムのエアロゾル送出 |
US7195882B2 (en) * | 2003-06-03 | 2007-03-27 | Roche Diagnostics Operations, Inc. | Monoclonal antibodies specific for buprenorphine and metabolites thereof |
US7759358B2 (en) * | 2003-07-23 | 2010-07-20 | Crooks Peter A | Oral bioavailable prodrugs |
US7589233B2 (en) * | 2003-07-29 | 2009-09-15 | Signature R&D Holdings, Llc | L-Threonine derivatives of high therapeutic index |
US7220842B2 (en) * | 2004-04-05 | 2007-05-22 | Dade Behring Inc. | Immunoassays for buprenorphine and norbuprenorphine |
-
2006
- 2006-03-28 GB GBGB0606124.6A patent/GB0606124D0/en not_active Ceased
-
2007
- 2007-03-27 JP JP2009502210A patent/JP5167446B2/ja not_active Expired - Fee Related
- 2007-03-27 MX MX2008011984A patent/MX2008011984A/es active IP Right Grant
- 2007-03-27 TW TW096110534A patent/TWI501969B/zh not_active IP Right Cessation
- 2007-03-27 MY MYPI20083500 patent/MY151025A/en unknown
- 2007-03-27 KR KR1020087023692A patent/KR101430626B1/ko not_active IP Right Cessation
- 2007-03-27 AU AU2007231133A patent/AU2007231133B2/en not_active Ceased
- 2007-03-27 WO PCT/GB2007/001120 patent/WO2007110636A1/en active Application Filing
- 2007-03-27 US US12/294,462 patent/US7964610B2/en not_active Expired - Fee Related
- 2007-03-27 RU RU2008142527/04A patent/RU2435773C2/ru not_active IP Right Cessation
- 2007-03-27 BR BRPI0709157A patent/BRPI0709157A8/pt not_active IP Right Cessation
- 2007-03-27 PL PL07732177T patent/PL2001891T3/pl unknown
- 2007-03-27 CN CNA2007800108118A patent/CN101410402A/zh active Pending
- 2007-03-27 NZ NZ570997A patent/NZ570997A/en not_active IP Right Cessation
- 2007-03-27 EP EP07732177.6A patent/EP2001891B1/en active Active
- 2007-03-27 CA CA2647417A patent/CA2647417C/en not_active Expired - Fee Related
- 2007-03-27 DK DK07732177.6T patent/DK2001891T3/da active
- 2007-03-27 PT PT77321776T patent/PT2001891E/pt unknown
- 2007-03-27 CN CN201410318622.9A patent/CN104151320A/zh active Pending
- 2007-03-27 ES ES07732177T patent/ES2432169T3/es active Active
-
2008
- 2008-09-04 ZA ZA200807614A patent/ZA200807614B/xx unknown
- 2008-09-04 IL IL193917A patent/IL193917A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2007110636A1 (en) | 2007-10-04 |
IL193917A (en) | 2014-12-31 |
NZ570997A (en) | 2011-08-26 |
CN104151320A (zh) | 2014-11-19 |
PT2001891E (pt) | 2013-10-30 |
PL2001891T3 (pl) | 2014-03-31 |
BRPI0709157A8 (pt) | 2018-04-24 |
KR101430626B1 (ko) | 2014-08-18 |
AU2007231133B2 (en) | 2011-09-01 |
GB0606124D0 (en) | 2006-05-03 |
AU2007231133A8 (en) | 2011-08-25 |
JP5167446B2 (ja) | 2013-03-21 |
JP2009531406A (ja) | 2009-09-03 |
BRPI0709157A2 (pt) | 2011-06-28 |
MY151025A (en) | 2014-03-31 |
CA2647417C (en) | 2014-09-23 |
US7964610B2 (en) | 2011-06-21 |
CN101410402A (zh) | 2009-04-15 |
MX2008011984A (es) | 2008-10-03 |
KR20080105124A (ko) | 2008-12-03 |
EP2001891B1 (en) | 2013-07-24 |
CA2647417A1 (en) | 2007-10-04 |
TW200806672A (en) | 2008-02-01 |
DK2001891T3 (da) | 2013-11-04 |
RU2435773C2 (ru) | 2011-12-10 |
EP2001891A1 (en) | 2008-12-17 |
US20100234412A1 (en) | 2010-09-16 |
AU2007231133A1 (en) | 2007-10-04 |
TWI501969B (zh) | 2015-10-01 |
AU2007231133A2 (en) | 2008-10-16 |
ES2432169T3 (es) | 2013-12-02 |
RU2008142527A (ru) | 2010-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200810323B (en) | Fkbp-l and uses thereof | |
TWI561237B (en) | Substituted dihydropyrazolones and their use | |
HK1117535A1 (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
PL2064327T3 (pl) | Dbait i ich zastosowania | |
HK1208000A1 (en) | Thioninium compounds and their use | |
IL247957A0 (en) | Anti-ephrinb2 antibodies and methods of using them | |
GB0621160D0 (en) | Compounds and uses thereof | |
HK1133552A1 (en) | Carboranylporphyrins and uses thereof | |
ZA200807614B (en) | Buprenorphine derivatives and uses thereof | |
GB0611115D0 (en) | Compounds and their use | |
EP2077262A4 (en) | IMINOPYRIDINE DERIVATIVES AND THEIR USE | |
EP2124908A4 (en) | CONNECTIONS AND ITS USE | |
EP2120563A4 (en) | CONNECTIONS AND ITS USES | |
EP2069371A4 (en) | ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE | |
GB0605295D0 (en) | Amino and derivatives | |
IL195430A0 (en) | Arylsulfonamidyl tetralin derivatives and uses thereof | |
GB0619611D0 (en) | Compounds and their use | |
GB0610059D0 (en) | Uses and methods | |
EP2099459A4 (en) | COMPOUNDS AND USES THEREOF | |
EP2120957A4 (en) | COMPOUNDS AND USES THEREOF | |
IL196823A0 (en) | Tetraarylporphine derivatives and uses thereof | |
GB2444960B (en) | Combined pseudoscope and hyperscope | |
GB0621665D0 (en) | Blogmail and podmail | |
GB0606794D0 (en) | Methods and uses | |
GB0614091D0 (en) | Compounds and their uses |